Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

5.560
+0.1302.39%
Volume:96.32M
Turnover:536.94M
Market Cap:64.18B
PE:14.17
High:5.700
Open:5.490
Low:5.440
Close:5.430
Loading ...

CSPC Pharmaceutical's Influenza Drug Gets China Nod for Registration

MT Newswires Live
·
15 Apr

CSPC Pharmaceutical - Oseltamivir Phosphate for Suspension Obtains Drug Registration Approval by Nmpa

THOMSON REUTERS
·
15 Apr

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtains Clinical Trial Approval In U.S.

Reuters
·
14 Apr

Executive Chairman of CSPC Pharmaceutical Group Dongchen Cai Buys More Stock

Simply Wall St.
·
12 Apr

BRIEF-CSPC Pharmaceutical Says SYH2046 Tablets Obtains Clinical Trial Approval From NMPA China

Reuters
·
11 Apr

CSPC Pharmaceutical Gets China Nod for Trial Of Cardiac Drug

MT Newswires Live
·
11 Apr

CSPC Pharma Gets US FDA Nod for Anti-Tumor Drug Trials

MT Newswires Live
·
09 Apr

BRIEF-CSPC Pharmaceutical Says Bi-Functional Fusion Protein Drug Obtains Clinical Trial Approval

Reuters
·
08 Apr

CSPC Pharmaceutical - Jmt108 (Bi-Functional Fusion Protein Drug) Obtained Approval From Nmpa to Conduct Clinical Trials in China

THOMSON REUTERS
·
08 Apr

CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Smaller Dividend Than Last Year

Simply Wall St.
·
05 Apr

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$6.55 From HK$6.48, Keeps at Buy

MT Newswires Live
·
31 Mar

CSPC Pharmaceutical's Out-Licensing Revenue Likely to be Sizeable Revenue Source -- Market Talk

Dow Jones
·
31 Mar

BRIEF-CSPC Pharmaceutical Posts FY Net Income RMB4,328 Million

Reuters
·
28 Mar

CSPC Pharmaceutical Group FY Revenue RMB 29,009 Million

THOMSON REUTERS
·
28 Mar

BRIEF-CSPC Pharmaceutical Says SYS6040 Obtains Clinical Trial Approval In China From NMPA

Reuters
·
21 Mar

CSPC Pharmaceutical - Sys6040 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in China From Nmpa

THOMSON REUTERS
·
21 Mar

BRIEF-CSPC Pharmaceutical Says FY Revenue For CSPC Innovation Pharmaceutical RMB1.98 Billion

Reuters
·
21 Mar

CSPC Pharmaceutical - FY Revenue for CSPC Innovation Pharmaceutical RMB1.98 Bln

THOMSON REUTERS
·
20 Mar

Greater China Stocks Close Mixed; Taiwan Leads Gainers

Dow Jones
·
20 Mar

3 Asian Penny Stocks With Market Caps Below US$8B

Simply Wall St.
·
19 Mar